No announcement yet.

CIDRAP NEWS SCAN: New Saudi MERS case; Rotavirus vaccine effects

  • Filter
  • Time
  • Show
Clear All
new posts

  • CIDRAP NEWS SCAN: New Saudi MERS case; Rotavirus vaccine effects


    News Scan for Apr 20, 2017
    New Saudi MERS case; Rotavirus vaccine effects

    Filed Under:
    MERS-CoV; Rotavirus Saudi Arabia reports new MERS case

    The Saudi Arabian Ministry of Health (MOH) confirmed a new MERS-CoV case today in Riyadh.
    The patient as identified as an 86-year-old Saudi man who is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus). His infection source is listed as primary, meaning he didn't likely contract the virus from another person.
    The MOH also reported the death in a case reported yesterday from Wadi Aldwasir. A 55-year-old expatriate man died, but it is not known if his illness was linked to the recent Wadi Aldwasir hospital outbreak.
    The news raises Saudi Arabia's overall total to 1,593 MERS cases, 660 of them fatal. Six people are still being treated for their illnesses.
    Apr 20 MOH update

    Rotavirus vaccine tied to 67% drop in serious cases of rotavirus diarrhea

    The introduction of rotavirus vaccines a decade ago has cut global hospitalizations and emergency department (ED) visits among young kids for diarrhea caused by rotavirus by 67% and for all causes of diarrhea by 38%, according to estimates published this week in the Journal of Infectious Diseases.
    Scientists from the US Centers for Disease Control and Prevention conducted a review of 57 studies involving patients in 27 countries since two rotavirus vaccines were licensed in 2006.
    They found that hospitalizations and ED visits in children 5 years and younger for rotavirus-related diarrhea dropped 67% overall since vaccine introduction and 71%, 59%, and 60% in low, medium, and high child mortality countries, respectively. For the same age-group for all-cause diarrhea, hospitalizations and ED visits declined 38% overall and 41%, 30%, 46% in low, medium, and high child mortality countries, respectively.
    An accompanying editorial notes that the study's findings coupled with new vaccine and funding efforts indicate that even more sickness can be avoided. Experts from the Chinese University of Hong Kong and the Bill & Melinda Gates Foundation note that India rolled out a new vaccine last year and expanded its reach this year. And, thanks to funding by Gavi, the Vaccine Alliance, two hard-hit African nations, Nigeria and the Democratic Republic of the Congo, will begin major immunization campaigns next year. In addition, India just licensed two new vaccines.
    Apr 18 J Infect Dis study
    Apr 18 J Infect Dis editorial